Alejandro Galindo - 18 May 2022 Form 4/A - Amendment Insider Report for MANNKIND CORP (MNKD)

Role
EVP Endocrine Business Unit
Signature
/s/ Alejandro Galindo
Issuer symbol
MNKD
Transactions as of
18 May 2022
Net transactions value
+$15,277
Form type
4/A - Amendment
Filing time
25 May 2022, 20:00:13 UTC
Date Of Original Report
25 May 2022
Previous filing
12 May 2022
Next filing
24 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNKD Common Stock, $.01 Par Value Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities $15,277 +4,789 +0.62% $3.19 776,690 18 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This report corrects total amount of securities beneficially owned as no shares were withheld to satisfy the tax liability incident on 5/18/2022 for the vesting of previously reported restricted stock units.